FDA NDC Directory · JSON-LD · Markdown

Venlafaxine

NDC 70771-1652 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA215622
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsVENLAFAXINE HYDROCHLORIDE (225 mg/1)
Marketing started20220901
Package count3

External sources

Source: openFDA. Public-domain (CC0).